• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

    3.400 +0.045 (+1.34%)
    Streaming Delayed Price Updated: 10:16 AM EDT, May 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 179,019
    Open 3.320
    Bid (Size) 3.400 (600)
    Ask (Size) 3.410 (600)
    Prev. Close 3.355
    Today's Range 3.320 - 3.435
    52wk Range 2.370 - 6.180
    Shares Outstanding 136,360,208
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
    Issued on behalf of VentriPoint Diagnostics Ltd. 
    From USA News Group
    Via GlobeNewswire
    News headline image
    Cytek (CTKB) Q1 2026 Earnings Call Transcript ↗
    Cytek (CTKB) Q1 2026 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    -30.9%
    -30.9%
    1 Month
    -26.4%
    -26.4%
    3 Month
    -18.5%
    -18.5%
    6 Month
    -25.6%
    -25.6%
    1 Year
    +24.5%
    +24.5%

    More News

    Read More
    News headline image
    Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
    From Cytek Biosciences, Inc.
    Via GlobeNewswire
    Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 5, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 6, 2025 ↗
    Via Benzinga
    News headline image
    Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For May 8, 2025 ↗
    Via Benzinga
    News headline image
    Cytek (CTKB) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Intellectual Property World Trade
    News headline image
    Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗
    Via Benzinga
    News headline image
    TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
    From Cytek Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For February 27, 2025 ↗
    Via Benzinga
    News headline image
    Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
    From Cytek Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Cytek (CTKB) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Intellectual Property World Trade
    News headline image
    Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
    From Cytek Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
    From Cytek Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
    From Cytek Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
    From Cytek Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Cytek Biosciences Reports First Quarter 2025 Financial Results
    From Cytek Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
    From Cytek Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
    From Cytek Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November ↗
    Via Benzinga
    News headline image
    Crude Oil Gains 1%; Chicago PMI Falls In December ↗
    Via Benzinga
    News headline image
    Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday ↗
    Via Benzinga

    Frequently Asked Questions

    Is Cytek Biosciences, Inc. - Common Stock publicly traded?
    Yes, Cytek Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Cytek Biosciences, Inc. - Common Stock trade on?
    Cytek Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Cytek Biosciences, Inc. - Common Stock?
    The ticker symbol for Cytek Biosciences, Inc. - Common Stock is CTKB on the Nasdaq Stock Market
    What is the current price of Cytek Biosciences, Inc. - Common Stock?
    The current price of Cytek Biosciences, Inc. - Common Stock is 3.400
    When was Cytek Biosciences, Inc. - Common Stock last traded?
    The last trade of Cytek Biosciences, Inc. - Common Stock was at 05/15/26 10:16 AM ET
    What is the market capitalization of Cytek Biosciences, Inc. - Common Stock?
    The market capitalization of Cytek Biosciences, Inc. - Common Stock is 463.62M
    How many shares of Cytek Biosciences, Inc. - Common Stock are outstanding?
    Cytek Biosciences, Inc. - Common Stock has 464M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.